Literature DB >> 1721822

CD4-gp120 interactions.

J S McDougal1, D R Klatzmann, P J Maddon.   

Abstract

The three-dimensional structure of the binding domain of the CD4 molecule has been determined and extensive mutational analyses of the respective binding sites on gp120 and CD4 have been completed. The consequences of gp120-CD4 binding with respect to secondary changes in the virion, or the cell, that may be required for infection or that may interfere with cellular function are current active areas of investigation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721822     DOI: 10.1016/0952-7915(91)90020-2

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  9 in total

Review 1.  The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection.

Authors:  C C Rider
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

2.  CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.

Authors:  W K Wang; T Dudek; Y J Zhao; H G Brumblay; M Essex; T H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 3.  Small-Molecule HIV Entry Inhibitors Targeting gp120 and gp41.

Authors:  Fei Yu; Shibo Jiang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Human immunodeficiency virus type 1 envelope glycoprotein molecules containing membrane fusion-impairing mutations in the V3 region efficiently undergo soluble CD4-stimulated gp120 release.

Authors:  E A Berger; J R Sisler; P L Earl
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

5.  Cyclodepsipeptides from marine sponges: natural agents for drug research.

Authors:  Gowri Shankar Bagavananthem Andavan; Rosa Lemmens-Gruber
Journal:  Mar Drugs       Date:  2010-03-22       Impact factor: 5.118

Review 6.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

7.  CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.

Authors:  C C Broder; E A Berger
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  CD4 and its role in infection of rabbit cell lines by human immunodeficiency virus type 1.

Authors:  B F Hague; S Sawasdikosol; T J Brown; K Lee; D P Recker; T J Kindt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 9.  Selective transmission of R5 HIV-1 variants: where is the gatekeeper?

Authors:  Jean-Charles Grivel; Robin J Shattock; Leonid B Margolis
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.